» Articles » PMID: 19913146

Continuation Rates and Reasons for Removal Among Implanon Users Accessing Two Family Planning Clinics in Queensland, Australia

Overview
Journal Contraception
Publisher Elsevier
Date 2009 Nov 17
PMID 19913146
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study examined demographic profile, continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.

Study Design: A retrospective chart audit of 976 women who attended for implant insertion over a 3-year period between May 2001 and May 2004.

Results: Continuation rates showed that at 6 months after insertion, 94% of women continued, 74% continued at 1 year and 50% continued at 2 years. Metropolitan women were more likely than rural women to discontinue use because of dissatisfaction with bleeding patterns. Cox regression analysis showed that those attending the regional clinic experienced significantly shorter time to removal.

Conclusions: Implanon continuation rates and reasons for removal differ between clinics in metropolitan and rural locations. A cooling-off period did not affect the likelihood of continuation with Implanon. Preinsertion counselling should emphasize potential changes in bleeding patterns.

Citing Articles

Determinants of implanon discontinuation among women in Gedeo Zone, South Ethiopia: a case-control study.

Bezabih T, Agidew S, Kebede S, Belay M, Siyoum E, Ashenafi E Contracept Reprod Med. 2024; 9(1):22.

PMID: 38741215 PMC: 11089669. DOI: 10.1186/s40834-024-00263-1.


Early discontinuation of the IMPLANON® and associated factors in Ethiopia, systematic review and meta-analysis.

Figa Z, Chekole T, Tarekegn D, Mahamed A, Bekele E Heliyon. 2023; 9(6):e15972.

PMID: 37251447 PMC: 10220320. DOI: 10.1016/j.heliyon.2023.e15972.


Reasons for modern contraceptives choice and long-acting reversible contraceptives early removal in Amhara Region, Northwest Ethiopia; qualitative approach.

Gashaye K, Gebresilassie K, Kassie B, Zenebe C, Mengistu Z, Ferede S BMC Womens Health. 2023; 23(1):273.

PMID: 37208658 PMC: 10199468. DOI: 10.1186/s12905-023-02375-3.


Acceptability and continuation of use of the subdermal contraceptive implant among adolescents and young women in Argentina: a retrospective cohort study.

Maceira D, Oizerovich S, Perrotta G, Ponce de Leon R, Karolinski A, Suarez N Sex Reprod Health Matters. 2023; 31(1):2189507.

PMID: 37042700 PMC: 10101666. DOI: 10.1080/26410397.2023.2189507.


Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.

Lombardi Fah V, Catarino R, Castillo S, Badda M, Gezer-Dickschat S, Thieringer F BMC Res Notes. 2023; 16(1):35.

PMID: 36915205 PMC: 10010063. DOI: 10.1186/s13104-023-06304-3.